SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma.

about

Constructing TC-1-GLUC-LMP2 Model Tumor Cells to Evaluate the Anti-Tumor Effects of LMP2-Related Vaccines.

P2860

Q54249887-D0A7B49B-0B5C-462D-B380-53B29810F954

P2860

SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma.

Item

http://www.wikidata.org/entity/Q48161285

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

SYK-targeted dendritic cell-me ...... munotherapy on retinoblastoma.

@en

SYK-targeted dendritic cell-me ...... munotherapy on retinoblastoma.

@nl

type

Item

label

SYK-targeted dendritic cell-me ...... munotherapy on retinoblastoma.

@en

SYK-targeted dendritic cell-me ...... munotherapy on retinoblastoma.

@nl

prefLabel

SYK-targeted dendritic cell-me ...... munotherapy on retinoblastoma.

@en

SYK-targeted dendritic cell-me ...... munotherapy on retinoblastoma.

@nl

P1476

SYK-targeted dendritic cell-me ...... munotherapy on retinoblastoma.

@en

P2093

Huqin Zhang

http://www.w3.org/2001/XMLSchema#string

Jianwei Lin

http://www.w3.org/2001/XMLSchema#string

Jinghan Huang

http://www.w3.org/2001/XMLSchema#string

Meiling Zhou

http://www.w3.org/2001/XMLSchema#string

Patricia Elena Kunda

http://www.w3.org/2001/XMLSchema#string

Xuemei Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma

Dendritic cells and the control of immunity

Cancer immunotherapy via dendritic cells

Podosomes of dendritic cells facilitate antigen sampling

FcγRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) Expression

Proteomic and genetic approaches identify Syk as an AML target.

Normal human pregnancy results in maternal immune activation in the periphery and at the uteroplacental interface.

Elevated double negative T cells in pediatric autoimmunity

Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target.

Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.

P2888

s00432-018-2584-x

P304

675-684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-018-2584-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

144

http://www.w3.org/2001/XMLSchema#string

P50

Tao Liu

P577

2018-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29372378

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

cytotoxicity

retinoblastoma

P932

5843685

http://www.w3.org/2001/XMLSchema#string

SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma.

about

P2860

P2860

SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932